How I Used This Simple “7-Second” Morning Habit to Trim Down 110 Pounds of Pure Fat

How I Used This Simple “7-Second” Morning Habit to Trim Down 110 Pounds of Pure Fat

Make sure your sound is turned on. Please wait up to 10 seconds for the video to load.

SCIENTIFIC REFERENCES


  1. Caroline I. Le Roy, Ruth C. E. Bowyer, Juan E. Castillo-Fernandez, Tess Pallister, Cristina Menni, Claire J. Steves, Sarah E. Berry, Tim D. Spector, & Jordana T. Bell. (2019, July 5). Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Scientific Reports, 9(1), 9758.

  2. Neha Alang & Colleen R. Kelly. (2015, February 1). Weight Gain After Fecal Microbiota Transplantation. Open Forum Infectious Diseases, 2(1), ofv004.

  3. Saffouri, G., Pardi, D., Kashyap, P., & Khanna, S. (2016). Body Mass Index Changes After Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. American Journal of Gastroenterology, 111(S103).

  4. Health at a Glance 2017: OECD Indicators. (2017). OECD.

  5. LaRosa, J. (2024, March 6). U.S. Weight Loss Industry Grows to $90 Billion, Fueled by Obesity Drugs Demand.

  6. Carter, J. (2022, February 1). That diet probably won’t work long-term — here’s what to focus on instead.

Komaroff, A. L. (2021, February 12). Do gut bacteria inhibit weight loss? Harvard Health Publishing.

  1. Guinane, C. M., & Cotter, P. D. (2013). Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therapeutics Advances in Gastroenterology, 6(4), 295–308.

  2. Alang, N., & Kelly, C. R. (2015). Weight Gain After Fecal Microbiota Transplantation. Open Forum Infectious Diseases, 2(1), ofv004.

  3. de Clercq, N. C., Frissen, M. N., Davids, M., Groen, A. K., & Nieuwdorp, M. (2019). Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa. Psychotherapy and Psychosomatics, 88(1), 58–60.

  4. Meijnikman, A. S., Aydin, O., Prodan, A., Tremaroli, V., Herrema, H., Levin, E., Acherman, Y., Bruin, S., Gerdes, V. E., Backhed, F., Groen, A. K., & Nieuwdorp, M. (2020). Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects. Journal of Internal Medicine, 288(1), 71–83.

  5. Caroline I. Le Roy, Ruth C. E. Bowyer, Juan E. Castillo-Fernandez, Tess Pallister, Cristina Menni, Claire J. Steves, Sarah E. Berry, Tim D. Spector, & Jordana T. Bell. (2019). Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Scientific Reports, 9(1), 9758.

  6. Smiley, J. D. (2022, April 27). Could the gut microbiome be responsible for food cravings? Medical News Today.

  7. Alcock, J., Maley, C. C., & Aktipis, C. A. (2014). Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. BioEssays, 36(10), 940–949.

  8. Quigley, E. M. M. (2013). Gut Bacteria in Health and Disease. Gastroenterology & Hepatology (New York), 9(9), 560–569.

  9. Takahashi, S., Anzawa, D., Takami, K., Ishizuka, A., Mawatari, T., Kamikado, K., Sugimura, H., & Nishijima, T. (2016). Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial. Bioscience, Microbiota, Food & Health, 35(4), 163–171.

  10. Sato, S., Arai, S., Kato, K., Yoshida, K., Iwabuchi, N., Sagami, T., & Tanaka, M. (2024). Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study. Nutrients, 16(6), 815.

  11. Long, J., Yang, J., Henning, S. M., Woo, S. L., Hsu, M., Chan, B., Heber, D., & Li, Z. (2019). Xylooligosaccharide supplementation decreases visceral fat accumulation and modulates cecum microbiome in mice. Journal of Functional Foods, 52, 138–146.

  12. Finegold, S. M., Li, Z., Summanen, P. H., Downes, J., Thames, G., Corbett, K., Dowd, S., Krak, M., & Heber, D. (2014). Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food & Function, 5(3).

  13. Yang, N., Lan, T., Han, Y., Zhao, H., Wang, C., Xu, Z., Chen, Z., Tao, M., Li, H., Song, Y., & Ma, X. (2023). Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice. PLoS ONE, 18(7), e0289364.

  14. Telesford, I., Schwartz, H., Claxton, G., & Cox, C. (2023, March 24). How have costs associated with obesity changed over time? KFF.


  1. Caroline I. Le Roy, Ruth C. E. Bowyer, Juan E. Castillo-Fernandez, Tess Pallister, Cristina Menni, Claire J. Steves, Sarah E. Berry, Tim D. Spector, & Jordana T. Bell. (2019, July 5). Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Scientific Reports, 9(1), 9758.

  2. Neha Alang & Colleen R. Kelly. (2015, February 1). Weight Gain After Fecal Microbiota Transplantation. Open Forum Infectious Diseases, 2(1), ofv004.

  3. Saffouri, G., Pardi, D., Kashyap, P., & Khanna, S. (2016). Body Mass Index Changes After Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. American Journal of Gastroenterology, 111(S103).

  4. Health at a Glance 2017: OECD Indicators. (2017). OECD.

  5. LaRosa, J. (2024, March 6). U.S. Weight Loss Industry Grows to $90 Billion, Fueled by Obesity Drugs Demand.

  6. Carter, J. (2022, February 1). That diet probably won’t work long-term — here’s what to focus on instead.

Komaroff, A. L. (2021, February 12). Do gut bacteria inhibit weight loss? Harvard Health Publishing.

  1. Guinane, C. M., & Cotter, P. D. (2013). Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therapeutics Advances in Gastroenterology, 6(4), 295–308.

  2. Alang, N., & Kelly, C. R. (2015). Weight Gain After Fecal Microbiota Transplantation. Open Forum Infectious Diseases, 2(1), ofv004.

  3. de Clercq, N. C., Frissen, M. N., Davids, M., Groen, A. K., & Nieuwdorp, M. (2019). Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa. Psychotherapy and Psychosomatics, 88(1), 58–60.

  4. Meijnikman, A. S., Aydin, O., Prodan, A., Tremaroli, V., Herrema, H., Levin, E., Acherman, Y., Bruin, S., Gerdes, V. E., Backhed, F., Groen, A. K., & Nieuwdorp, M. (2020). Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects. Journal of Internal Medicine, 288(1), 71–83.

  5. Caroline I. Le Roy, Ruth C. E. Bowyer, Juan E. Castillo-Fernandez, Tess Pallister, Cristina Menni, Claire J. Steves, Sarah E. Berry, Tim D. Spector, & Jordana T. Bell. (2019). Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Scientific Reports, 9(1), 9758.

  6. Smiley, J. D. (2022, April 27). Could the gut microbiome be responsible for food cravings? Medical News Today.

  7. Alcock, J., Maley, C. C., & Aktipis, C. A. (2014). Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. BioEssays, 36(10), 940–949.

  8. Quigley, E. M. M. (2013). Gut Bacteria in Health and Disease. Gastroenterology & Hepatology (New York), 9(9), 560–569.

  9. Takahashi, S., Anzawa, D., Takami, K., Ishizuka, A., Mawatari, T., Kamikado, K., Sugimura, H., & Nishijima, T. (2016). Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial. Bioscience, Microbiota, Food & Health, 35(4), 163–171.

  10. Sato, S., Arai, S., Kato, K., Yoshida, K., Iwabuchi, N., Sagami, T., & Tanaka, M. (2024). Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study. Nutrients, 16(6), 815.

  11. Long, J., Yang, J., Henning, S. M., Woo, S. L., Hsu, M., Chan, B., Heber, D., & Li, Z. (2019). Xylooligosaccharide supplementation decreases visceral fat accumulation and modulates cecum microbiome in mice. Journal of Functional Foods, 52, 138–146.

  12. Finegold, S. M., Li, Z., Summanen, P. H., Downes, J., Thames, G., Corbett, K., Dowd, S., Krak, M., & Heber, D. (2014). Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food & Function, 5(3).

  13. Yang, N., Lan, T., Han, Y., Zhao, H., Wang, C., Xu, Z., Chen, Z., Tao, M., Li, H., Song, Y., & Ma, X. (2023). Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice. PLoS ONE, 18(7), e0289364.

  14. Telesford, I., Schwartz, H., Claxton, G., & Cox, C. (2023, March 24). How have costs associated with obesity changed over time? KFF.

  1. Caroline I. Le Roy, Ruth C. E. Bowyer, Juan E. Castillo-Fernandez, Tess Pallister, Cristina Menni, Claire J. Steves, Sarah E. Berry, Tim D. Spector, & Jordana T. Bell. (2019, July 5). Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Scientific Reports, 9(1), 9758.

  2. Neha Alang & Colleen R. Kelly. (2015, February 1). Weight Gain After Fecal Microbiota Transplantation. Open Forum Infectious Diseases, 2(1), ofv004.

  3. Saffouri, G., Pardi, D., Kashyap, P., & Khanna, S. (2016). Body Mass Index Changes After Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. American Journal of Gastroenterology, 111(S103).

  4. Health at a Glance 2017: OECD Indicators. (2017). OECD.

  5. LaRosa, J. (2024, March 6). U.S. Weight Loss Industry Grows to $90 Billion, Fueled by Obesity Drugs Demand.

  6. Carter, J. (2022, February 1). That diet probably won’t work long-term — here’s what to focus on instead.

Komaroff, A. L. (2021, February 12). Do gut bacteria inhibit weight loss? Harvard Health Publishing.

  1. Guinane, C. M., & Cotter, P. D. (2013). Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therapeutics Advances in Gastroenterology, 6(4), 295–308.

  2. Alang, N., & Kelly, C. R. (2015). Weight Gain After Fecal Microbiota Transplantation. Open Forum Infectious Diseases, 2(1), ofv004.

  3. de Clercq, N. C., Frissen, M. N., Davids, M., Groen, A. K., & Nieuwdorp, M. (2019). Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa. Psychotherapy and Psychosomatics, 88(1), 58–60.

  4. Meijnikman, A. S., Aydin, O., Prodan, A., Tremaroli, V., Herrema, H., Levin, E., Acherman, Y., Bruin, S., Gerdes, V. E., Backhed, F., Groen, A. K., & Nieuwdorp, M. (2020). Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects. Journal of Internal Medicine, 288(1), 71–83.

  5. Caroline I. Le Roy, Ruth C. E. Bowyer, Juan E. Castillo-Fernandez, Tess Pallister, Cristina Menni, Claire J. Steves, Sarah E. Berry, Tim D. Spector, & Jordana T. Bell. (2019). Dissecting the role of the gut microbiota and diet on visceral fat mass accumulation. Scientific Reports, 9(1), 9758.

  6. Smiley, J. D. (2022, April 27). Could the gut microbiome be responsible for food cravings? Medical News Today.

  7. Alcock, J., Maley, C. C., & Aktipis, C. A. (2014). Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. BioEssays, 36(10), 940–949.

  8. Quigley, E. M. M. (2013). Gut Bacteria in Health and Disease. Gastroenterology & Hepatology (New York), 9(9), 560–569.

  9. Takahashi, S., Anzawa, D., Takami, K., Ishizuka, A., Mawatari, T., Kamikado, K., Sugimura, H., & Nishijima, T. (2016). Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial. Bioscience, Microbiota, Food & Health, 35(4), 163–171.

  10. Sato, S., Arai, S., Kato, K., Yoshida, K., Iwabuchi, N., Sagami, T., & Tanaka, M. (2024). Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study. Nutrients, 16(6), 815.

  11. Long, J., Yang, J., Henning, S. M., Woo, S. L., Hsu, M., Chan, B., Heber, D., & Li, Z. (2019). Xylooligosaccharide supplementation decreases visceral fat accumulation and modulates cecum microbiome in mice. Journal of Functional Foods, 52, 138–146.

  12. Finegold, S. M., Li, Z., Summanen, P. H., Downes, J., Thames, G., Corbett, K., Dowd, S., Krak, M., & Heber, D. (2014). Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food & Function, 5(3).

  13. Yang, N., Lan, T., Han, Y., Zhao, H., Wang, C., Xu, Z., Chen, Z., Tao, M., Li, H., Song, Y., & Ma, X. (2023). Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice. PLoS ONE, 18(7), e0289364.

  14. Telesford, I., Schwartz, H., Claxton, G., & Cox, C. (2023, March 24). How have costs associated with obesity changed over time? KFF.

Disclaimer: Content and statements on this website have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It should not be substituted for medical advice or medical intervention. Please consult a qualified healthcare provider when making medical decisions. Exercise and a healthy diet are necessary to achieve and maintain weight loss.

Disclaimer: Content and statements on this website have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It should not be substituted for medical advice or medical intervention. Please consult a qualified healthcare provider when making medical decisions. Exercise and a healthy diet are necessary to achieve and maintain weight loss.

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Always consult with a qualified healthcare professional prior to beginning any diet or exercise program or taking any dietary supplement. The content on this website is for informational and educational purposes only and is not intended as medical advice or to replace a relationship with a qualified healthcare professional.